Startup profile · funding coverage
Solugen funding, valuation and investors
Chemi-enzymatic Bioforge platform making low-carbon chemicals from plant sugars instead of petroleum.
Keep track of Solugen
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Not publicly disclosed
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · Houston, TX
Overview
Solugen reimagines chemical manufacturing with a chemi-enzymatic platform (enzyme engineering + metal catalysis) producing organic acids and specialty molecules from renewable feedstocks. Founded by Gaurab Chakrabarti and Sean Hunt; HQ Houston with Bioforge Houston production and a large Marshall, MN expansion with ADM. Raised Series C >$350M (GIC/Baillie Gifford-led) and Series D >$200M; CNBC reported $640M+ venture funding before a June 2024 DOE LPO conditional commitment of $213.6M.
Why Solugen is interesting
Houston climate-manufacturing scale-up: $640M+ venture capital (Founders Fund, GIC, Temasek, BlackRock, etc.) plus $213.6M DOE loan commitment for Bioforge Marshall — HQ/R&D stays in Houston.
Product & use cases
Modular Bioforge plants convert biomass-derived sugars into high-demand chemicals for water treatment, construction, agriculture, cleaning, and energy markets.
- Industrial water treatment chemistries
- Lower-carbon concrete admixtures and building materials
- Agriculture and cleaning specialty chemicals
Key facts
- DOE LPO (Jun 2024): $213.6M conditional loan guarantee for Bioforge Marshall
- Venture capital $640M+ reported (Baillie Gifford, GIC, Temasek, BlackRock, Founders Fund, Fifty Years, Refactor)
- HQ + R&D: Houston; Midwest manufacturing expansion with ADM
- Product: plant-sugar → specialty chemicals replacing fossil routes
Funding history (newest first)
DOE loan commitment
2024-06 $213.6M- U.S. DOE Loan Programs Office (lead)
Investors in our directory
Funds linked from Solugen's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Integrated enzyme + catalysis manufacturing with Houston scale-up history and federal loan support for U.S. biomanufacturing capacity.
-
Traditional petrochemical producers incumbent
Fossil-route commodity chemicals.
-
Other industrial biotech chemical startups direct
Bio-based chemical platforms.
-
Commodity ag processors adjacent
Feedstock partners/competitors on molecules.
Notable stories
- Co-founders rebuilt a Houston brownfield chemical site into Bioforge Houston before expanding to Minnesota — using Texas as the R&D and first commercial forge.
Industries
Related funding articles
Venture Capital Tracker pieces that cover Solugen's financing or category context.
FAQs about Solugen
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.